InsidersTradesSigma
한스바이오메드: management transactions · South Korea · DART (FSS)
DART:company-f6f123KR·DART (FSS)Mcap 236.0Bn€
Browse the full insider trade history of 한스바이오메드, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Market capitalisation: €236bn. The latest transaction was reported on 4 May 2026 — Sale. Among the most active insiders: KB자산운용. All data is accessible without an account.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
2 ops.
Sell Volume
Financial data
FY ended September 2025 · cache
23900.00 €
Income statement
Revenue89.78 Bn€
Gross profit51.51 Bn€57% margin
Net income−31.34 Bn€-34.9% margin
Balance sheet & cash
Market cap235.97 Bn€
Total debt43.31 Bn€
Free Cash Flow−1.44 Bn€
Last declaration on 4 May 2026